Antiproliferative Activity of Platinum(II) and Copper(II) Complexes Containing Novel Biquinoxaline Ligands

Overview

Journal Metallomics

Publisher Oxford University Press

Date 2024 Jan 6

PMID 38183277

Authors

Hager Sadek El-Beshti

Zuhal Gercek

Hakan Kayi

Yasemin Yildizhan

Yuksel Cetin

Zelal Adiguzel

Gamze Gungor

Seniz Ozalp-Yaman

Affiliations

Soon will be listed here.

Abstract

Nowadays, cancer represents one of the major causes of death in humans worldwide, which renders the quest for new and improved antineoplastic agents to become an urgent issue in the field of biomedicine and human health. The present research focuses on the synthesis of 2,3,2',3'-tetra(pyridin-2-yl)-6,6'-biquinoxaline) and (2,3,2',3'-tetra(thiophen-2-yl)-6,6'-biquinoxaline) containing copper(II) and platinum(II) compounds as prodrug candidates. The binding interaction of these compounds with calf thymus DNA (CT-DNA) and human serum albumin were assessed with UV titration, thermal decomposition, viscometric, and fluorometric methods. The thermodynamical parameters and the temperature-dependent binding constant (K'b) values point out to spontaneous interactions between the complexes and CT-DNA via the van der Waals interactions and/or hydrogen bonding, except Cu(ttbq)Cl2 for which electrostatic interaction was proposed. The antitumor activity of the complexes against several human glioblastomata, lung, breast, cervix, and prostate cell lines were investigated by examining cell viability, oxidative stress, apoptosis-terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling, in vitro migration and invasion, in vitro-comet DNA damage, and plasmid DNA interaction assays. The U87 and HeLa cells were investigated as the cancer cells most sensitive to our complexes. The exerted cytotoxic effect of complexes was attributed to the formation of the reactive oxygen species in vitro. It is clearly demonstrated that Cu(ttbq)Cl2, Pt(ttbq)Cl2, and Pt(tpbq)Cl2 have the highest DNA degradation potential and anticancer effect among the tested complexes by leading apoptosis. The wound healing and invasion analysis results also supported the higher anticancer activity of these two compounds.

References

Rehman S, Yaseen Z, Husain M, Sarwar T, Ishqi H, Tabish M . Interaction of 6 mercaptopurine with calf thymus DNA--deciphering the binding mode and photoinduced DNA damage. PLoS One. 2014; 9(4):e93913. PMC: 3981731. DOI: 10.1371/journal.pone.0093913. View

Deegan C, Coyle B, McCann M, Devereux M, Egan D . In vitro anti-tumour effect of 1,10-phenanthroline-5,6-dione (phendione), [Cu(phendione)3](ClO4)2.4H2O and [Ag(phendione)2]ClO4 using human epithelial cell lines. Chem Biol Interact. 2006; 164(1-2):115-25. DOI: 10.1016/j.cbi.2006.08.025. View

Silva D, Cortez C, Cunha-Bastos J, Louro S . Methyl parathion interaction with human and bovine serum albumin. Toxicol Lett. 2004; 147(1):53-61. DOI: 10.1016/j.toxlet.2003.10.014. View

Olive P, Banath J . The comet assay: a method to measure DNA damage in individual cells. Nat Protoc. 2007; 1(1):23-9. DOI: 10.1038/nprot.2006.5. View

LERMAN L . Structural considerations in the interaction of DNA and acridines. J Mol Biol. 1961; 3:18-30. DOI: 10.1016/s0022-2836(61)80004-1. View

Devereux M, McCann M, OShea D, OConnor M, Kiely E, McKee V . Synthesis, Superoxide Dismutase Mimetic and Anticancer Activities of Metal Complexes of 2,2-Dimethylpentanedioic Acid(2dmepdaH(2)) and 3,3-Dimethylpentanedioic acid(3dmepdaH(2)): X-Ray Crystal Structures of [Cu(3dmepda)(bipy)](2). 6H(2)O and.... Bioinorg Chem Appl. 2007; :80283. PMC: 1779549. DOI: 10.1155/BCA/2006/80283. View

Matos C, Adiguzel Z, Yildizhan Y, Cevatemre B, Onder T, Cevik O . May iron(III) complexes containing phenanthroline derivatives as ligands be prospective anticancer agents?. Eur J Med Chem. 2019; 176:492-512. DOI: 10.1016/j.ejmech.2019.04.070. View

Marzano C, Pellei M, Tisato F, Santini C . Copper complexes as anticancer agents. Anticancer Agents Med Chem. 2009; 9(2):185-211. DOI: 10.2174/187152009787313837. View

Gu S, Yu P, Hu J, Liu Y, Li Z, Qian Y . Mitochondria-localizing N-heterocyclic thiosemicarbazone copper complexes with good cytotoxicity and high antimetastatic activity. Eur J Med Chem. 2019; 164:654-664. DOI: 10.1016/j.ejmech.2019.01.014. View

10.

Deegan C, McCann M, Devereux M, Coyle B, Egan D . In vitro cancer chemotherapeutic activity of 1,10-phenanthroline (phen), [Ag2(phen)3(mal)]x2H2O, [Cu(phen)2(mal)]x2H2O and [Mn(phen)2(mal)]x2H2O (malH2=malonic acid) using human cancer cells. Cancer Lett. 2006; 247(2):224-33. DOI: 10.1016/j.canlet.2006.04.006. View

11.

Connors T, Jones M, Ross W, Braddock P, Khokhar A, Tobe M . New platinum complexes with anti-tumour activity. Chem Biol Interact. 1972; 5(6):415-24. DOI: 10.1016/0009-2797(72)90078-6. View

12.

Kandagal P, Ashoka S, Seetharamappa J, Shaikh S, Jadegoud Y, Ijare O . Study of the interaction of an anticancer drug with human and bovine serum albumin: spectroscopic approach. J Pharm Biomed Anal. 2006; 41(2):393-9. DOI: 10.1016/j.jpba.2005.11.037. View

13.

Chen L, Liu J, Chen J, Tan C, Shi S, Zheng K . Synthesis, characterization, DNA-binding and spectral properties of complexes [Ru(L)4(dppz)]2+ (L=Im and MeIm). J Inorg Biochem. 2007; 102(2):330-41. DOI: 10.1016/j.jinorgbio.2007.09.006. View

14.

Li F, Zhao G, Wu H, Lin H, Wu X, Zhu S . Synthesis, characterization and biological activity of lanthanum(III) complexes containing 2-methylene-1,10-phenanthroline units bridged by aliphatic diamines. J Inorg Biochem. 2005; 100(1):36-43. DOI: 10.1016/j.jinorgbio.2005.09.012. View

15.

Nikolis N, Methenitis C, Pneumatikakis G . Studies on the interaction of altromycin B and its platinum(II) and palladium(II) metal complexes with calf thymus DNA and nucleotides. J Inorg Biochem. 2003; 95(2-3):177-93. DOI: 10.1016/s0162-0134(03)00102-8. View

16.

Kostova I . Platinum complexes as anticancer agents. Recent Pat Anticancer Drug Discov. 2008; 1(1):1-22. DOI: 10.2174/157489206775246458. View

17.

Yu C, Gao C, Bai L, Liu Q, Zhang Z, Zhang Y . Design, synthesis and biological evaluation of six dinuclear platinum(II) complexes. Bioorg Med Chem Lett. 2017; 27(4):963-966. DOI: 10.1016/j.bmcl.2016.12.084. View

18.

Nair R, Teng E, Kirkland S, Murphy C . Synthesis and DNA-Binding Properties of [Ru(NH(3))(4)dppz](2+). Inorg Chem. 2001; 37(1):139-141. DOI: 10.1021/ic970432j. View

19.

Fei B, Tu S, Wei Z, Wang P, Qiao C, Chen Z . Optically pure chiral copper(II) complexes of rosin derivative as attractive anticancer agents with potential anti-metastatic and anti-angiogenic activities. Eur J Med Chem. 2019; 176:175-186. DOI: 10.1016/j.ejmech.2019.05.030. View

20.

Pizarro A, Sadler P . Unusual DNA binding modes for metal anticancer complexes. Biochimie. 2009; 91(10):1198-211. PMC: 2923023. DOI: 10.1016/j.biochi.2009.03.017. View